Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -151,822 | -99,807 | -67,124 | -47,599 | -24,251 |
| Depreciation Amortization | 3,046 | 2,827 | 1,592 | 862 | 419 |
| Income taxes - deferred | -293 | 99 | 131 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,166 | -771 | 451 | -179 | 2,224 |
| Other Working Capital | 9,580 | -784 | 872 | -1,099 | 3,241 |
| Other Operating Activity | 36,862 | 16,833 | 7,339 | 6,656 | -371 |
| Operating Cash Flow | $-101,461 | $-81,603 | $-56,739 | $-41,359 | $-18,738 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,122 | -11,098 | -7,164 | -3,879 | -1,019 |
| Purchase Of Investment | -267,522 | -50,726 | -152,812 | -126,261 | -97,810 |
| Sale Of Investment | 194,488 | 140,622 | 111,041 | 109,725 | 22,490 |
| Purchase Sale Intangibles | -330 | -351 | N/A | N/A | N/A |
| Other Investing Activity | -330 | -351 | 0 | 0 | 0 |
| Investing Cash Flow | $-88,486 | $78,447 | $-48,935 | $-20,415 | $-76,339 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 256 | 1,217 | 1,189 | 391 | 100 |
| Other Financing Activity | -131 | 130,921 | 133,510 | 79,132 | 122,840 |
| Financing Cash Flow | $125 | $132,138 | $134,699 | $79,523 | $122,940 |
| Beginning Cash Position | 223,720 | 94,738 | 65,713 | 47,964 | 20,101 |
| End Cash Position | 33,898 | 223,720 | 94,738 | 65,713 | 47,964 |
| Net Cash Flow | $-189,822 | $128,982 | $29,025 | $17,749 | $27,863 |
| Free Cash Flow | |||||
| Operating Cash Flow | -101,461 | -81,603 | -56,739 | -41,359 | -18,738 |
| Capital Expenditure | -15,122 | -11,098 | -7,164 | -3,879 | -1,019 |
| Free Cash Flow | -116,583 | -92,701 | -63,903 | -45,238 | -19,757 |